abstract |
The invention relates to the use of acridine or acridine derivatives, preferably in combination with benzalkonium chloride, for the inactivation of enveloped or non-enveloped viruses. The process according to the invention is preferably carried out in the presence of proteins, the biological activity of which is largely retained. |